Skip to main content

Table 3 IC50 values of anti-cancer drugs for pancreatic cancer cell lines

From: Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2

Drug

5-FU (μM)

GEM (nM)

IRI (μM)

OXA (μM)

PTX (nM)

OCUP-A1

51.1 ± 5.1

6.60 ± 1.4

5.21 ± 0.20

17.6 ± 0.94

15.7 ± 0.60

OCUP-A2

23.8 ± 6.3

6.01 ± 0.60

1.67 ± 0.075*

1.63 ± 0.070*

3.63 ± 0.14*

Panc-1

24.2 ± 12

59.2 ± 5.5***

8.90 ± 0.49***

9.25 ± 1.4

27.8 ± 0.95***

MIAPaCa-2

10.7 ± 2.4*

24.0 ± 10***

15.3 ± 0.28***

20.1 ± 0.91**

6.92 ± 0.14*,**

RWP-1

11.6 ± 1.8*

4.45 ± 1.3

7.02 ± 0.50***

18.4 ± 0.88

3.45 ± 0.046*

SW1990

68.2 ± 15**

92.0 ± 4.3***

10.5 ± 0.47***

72.9 ± 6.8***

21.3 ± 0.86***

  1. 5-FU 5-fluorouracil, GEM gemcitabine, IRI irinotecan, OXA oxaliplatin, PTX paclitaxel
  2. *vs OCUP-A1; p < 0.05
  3. **vs OCUP-A2; p < 0.05
  4. ***vs OCUP-A1 and OCUP-A2; p < 0.05